Back to search
Pediatric Homozygous Familial Hypercholesterolemia (HoFH)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Pediatric Homozygous Familial Hypercholesterolemia (HoFH) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Pediatric Homozygous Familial Hypercholesterolemia (HoFH) trials you may qualify forThe purpose of this open-label, single arm, multicenter extension study is to evaluate the long-term safety and tolerability of inclisiran in participants with…
The goal of this clinical trial is to identify different types of Familial Hypercholesterolemia (FH) in infants and newborns. Participants will: * undergo a ch…
This is a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in children (aged 2 to \<12 years) with homozygous famil…
This was a pivotal phase III study designed to evaluate safety, tolerability, and efficacy of inclisiran in adolescents with homozygous familial hypercholestero…
Provide compassionate use of evinacumab
The primary objective for Part A of the study is to assess the pharmacokinetics (PK) of evinacumab in pediatric patients with homozygous familial hypercholester…